Technical Analysis for MBIO - Mustang Bio, Inc.

Grade Last Price % Change Price Change
grade C 4.29 -3.81% -0.17
MBIO closed down 3.81 percent on Tuesday, September 17, 2019, on 54 percent of normal volume.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical MBIO trend table...

Date Alert Name Type % Chg
Overbought Stochastic Strength 0.00%
Upper Bollinger Band Walk Strength -3.81%
Overbought Stochastic Strength -3.81%
Upper Bollinger Band Touch Strength -3.81%
Pocket Pivot Bullish Swing Setup -6.94%
Stochastic Reached Overbought Strength -6.94%
Overbought Stochastic Strength -6.94%
Upper Bollinger Band Touch Strength -6.94%
Inside Day Range Contraction -3.16%
Up 3 Days in a Row Strength -5.30%

Older signals for MBIO ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Mustang Bio, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of cancer immunotherapy products designed to utilize the power of the patient’s own immune system to eliminate cancer cells. It seeks to acquire rights to technologies by licensing or otherwise acquiring an ownership interest in the technologies, funding their research and development and eventually either out-licensing or bringing the technologies to market. The Company is developing its proprietary Chimeric Antigen Receptor (CAR) engineered T cells (CAR -T) technology, which uses the patient’s own T cells to engage and destroy specific tumors. The Company, through its agreement with City of Hope National Medical Center, is using three novel CAR T therapies in the development of cancer treatments, including human epidermal growth factor receptor 2 CAR T technology, CS1-specific CAR T technology, and prostate stem cell antigen CAR T technology.
Medicine Biopharmaceutical Cancer Immunotherapy Immune System Cancer Treatments Gene Therapy Cancer Immunotherapy Virotherapy Kite Pharma Chimeric Antigen Receptor Cancer Immunotherapy Products Cellectis T Cell
Is MBIO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 10.2
52 Week Low 2.18
Average Volume 273,495
200-Day Moving Average 3.6634
50-Day Moving Average 3.6274
20-Day Moving Average 4.1645
10-Day Moving Average 4.261
Average True Range 0.3298
ADX 38.65
+DI 26.6645
-DI 11.1133
Chandelier Exit (Long, 3 ATRs ) 3.8606
Chandelier Exit (Short, 3 ATRs ) 4.5994
Upper Bollinger Band 4.7169
Lower Bollinger Band 3.6121
Percent B (%b) 0.61
BandWidth 26.528995
MACD Line 0.2251
MACD Signal Line 0.2088
MACD Histogram 0.0163
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.73
Resistance 3 (R3) 4.77 4.66 4.65
Resistance 2 (R2) 4.66 4.55 4.64 4.63
Resistance 1 (R1) 4.48 4.48 4.43 4.44 4.60
Pivot Point 4.37 4.37 4.35 4.35 4.37
Support 1 (S1) 4.19 4.26 4.14 4.15 3.98
Support 2 (S2) 4.08 4.19 4.06 3.95
Support 3 (S3) 3.90 4.08 3.93
Support 4 (S4) 3.86